Toth Financial Advisory’s Roivant Sciences ROIV Stock Holding History

Toth Financial Advisory’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.54K	Sell	100 -50	-33%	-$1.48K	﹤0.01%	690
2026 Q1	$4.16K	Hold	150	–	–	﹤0.01%	658
2025 Q4	$3.25K	Hold	150	–	–	﹤0.01%	669
2025 Q3	$2.27K	Hold	150	–	–	﹤0.01%	682
2025 Q2	$1.69K	Hold	150	–	–	﹤0.01%	657
2025 Q1	$1.51K	Hold	150	–	–	﹤0.01%	628
2024 Q4	$1.77K	Sell	150 -120	-44%	-$1.42K	﹤0.01%	599
2024 Q3	$3.12K	Buy	270 +120	+80%	+$1.37K	﹤0.01%	551
2024 Q2	$1.59K	Hold	150	–	–	﹤0.01%	636
2024 Q1	$1.58K	Buy	+150	New	+$1.62K	﹤0.01%	634

Other funds holding ROIV

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Toth Financial Advisory's ROIV Position: Q2 2026 in Review

Toth Financial Advisory reduced its Roivant Sciences (ROIV) stake by 33% in Q2 2026, selling an estimated $1.48K and leaving 100 shares worth $3.54K. The position accounts for ﹤0.01% of the portfolio, ranked #690.

Toth Financial Advisory first reported a position in ROIV in Q1 2024 and has held it in 10 quarters since. The position peaked at $4.16K in Q1 2026. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

Toth Financial Advisory held 100 shares of Roivant Sciences worth $3.54K as of Q2 2026.
Toth Financial Advisory sold 50 Roivant Sciences shares in Q2 2026, an estimated $1.48K.
Roivant Sciences made up ﹤0.01% of Toth Financial Advisory's portfolio in Q2 2026, its #690 holding.
Toth Financial Advisory first reported a position in Roivant Sciences in Q1 2024 and has held it in 10 quarters since.
Toth Financial Advisory's Roivant Sciences position peaked at $4.16K in Q1 2026.
498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Toth Financial Advisory's 13F filing for Q2 2026, filed 14 Jul 2026.